Details for New Drug Application (NDA): 204522
✉ Email this page to a colleague
The generic ingredient in PHENOXYBENZAMINE HYDROCHLORIDE is phenoxybenzamine hydrochloride. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.
Summary for 204522
Tradename: | PHENOXYBENZAMINE HYDROCHLORIDE |
Applicant: | Par Pharm Inc |
Ingredient: | phenoxybenzamine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 204522
Mechanism of Action | Adrenergic alpha-Antagonists |
Medical Subject Heading (MeSH) Categories for 204522
Suppliers and Packaging for NDA: 204522
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PHENOXYBENZAMINE HYDROCHLORIDE | phenoxybenzamine hydrochloride | CAPSULE;ORAL | 204522 | ANDA | Par Pharmaceutical, Inc. | 49884-038 | 49884-038-01 | 100 CAPSULE in 1 BOTTLE (49884-038-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
Approval Date: | Jan 24, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription